Report
Alex Morozov
EUR 100.00 For Business Accounts Only

Thermo Fisher Continues Its Strong Growth Momentum in 3Q

Thermo Fisher Scientific reported strong third-quarter results at 16% revenue growth, or 10% in organic terms. As a result, the firm raised its full-year guidance on the revenue and earnings lines, expecting 15% revenue growth and 16%-17% EPS growth year on year (previous guidance at 13%-14% revenue growth and 15%-16% EPS growth over 2017). We plan to slightly adjust our 2018 numbers to account for the better-than-expected operational environment, but not enough to result in a material change t...
Underlying
Thermo Fisher Scientific Inc.

Thermo Fisher Scientific is engaged in serving science. The company's segments include: Life Sciences Solutions, which provides reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines as well as diagnosis of disease; Analytical Instruments, which provides instruments, consumables, software and services that are used for a range of applications in the laboratory, on the production line and in the field; and Specialty Diagnostics, which provides diagnostic test kits, reagents, culture media, instruments and associated products for customers in healthcare, clinical, pharmaceutical, industrial, and food safety laboratories.

Provider
Morningstar
Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

Analysts
Alex Morozov

Other Reports on these Companies
Other Reports from Morningstar

ResearchPool Subscriptions

Get the most out of your insights

Get in touch